Intravesical instillation with live, attenuated Mycobacterium Bacillus Calmette-Guérin (BCG) is an effective therapy for bladder cancer. Two recent analyses provide new insight into the clinical ...

Existing phase 2 data on CG0070 in Bacillus Calmette–Guérin-unresponsive patients with nonmuscle invasive bladder cancer show a robust complete response rate, with durable responses seen in a ...

Tuberculosis reclaims its title as the deadliest infectious disease, with 1.25 million deaths in 2023, WHO emphasizes urgent ...

The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...

BCG (Bacillus Calmette-Guerin) vaccine for tuberculosis, pictured at the Pasteur Institute in Paris in 1931. Scientists in the UK have begun testing the BCG vaccine, developed in 1921, to see if ...

The Department of Health on Tuesday launched a catch-up vaccination drive to increase the fully-immunized children (FIC) ...

Bacillus of Calmette and Guerin (BCG) strain of Mycobacterium bovis live, attenuated culture preparation; 50mg per vial; pwd for intravesical administration after reconstitution and dilution ...

The only vaccine against TB, the Bacillus Calmette-Guérin vaccine, has been used for more than 100 years. It is largely effective for children under five, but less so in older people. And it can ...

BOSTON & MONTREAL, November 25, 2024--enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), a clinical-stage ...